Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%

Last updated on 2020-01-16 History
Report ID 90052
Drug Identification Number 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CALCIUM GLUCONATE
Strength(s) 94MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 50mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-07-26
Estimated end date 2019-10-08
Actual end date 2019-10-07
Shortage status Resolved
Updated date 2020-01-16
Company comments Product available
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-07-26 English Compare
v2 2019-07-26 English Compare
v3 2019-07-26 French Compare
v4 2019-07-27 English Compare
v5 2019-10-01 English Compare
v6 2019-10-01 French Compare
v7 2020-01-16 English Compare
v8 2020-01-16 French Compare

Showing 1 to 8 of 8